ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00423748
Recruitment Status : Completed
First Posted : January 18, 2007
Last Update Posted : April 16, 2009
Sponsor:
Information provided by:
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : February 2006